We are a one-stop shop Healthcare Advisory & Consulting boutique and we help businesses with funding, market access, business strategy, distribution.
+ 34-608-087-655
nsaglio@yahoo.co.uk
Title Image

Blog

Home  /  Funding   /  Shape Therapeutics raises $35.5M Series A round to develop RNA-based gene editing technology

Shape Therapeutics raises $35.5M Series A round to develop RNA-based gene editing technology

A company developing a means to edit RNA has raised more than $30 million in a venture capital funding round.

Seattle-based Shape Therapeutics, or ShapeTx, said that it had raised a $35.5 million Series A financing, led by New Enterprise Associates and with participation from CureDuchenne Ventures. The company said it plans to use the money to build up its intellectual property, hire scientists and advance its RNA and protein-targeting technology, which it describes as being aimed at curing genetic diseases.

Read More